Google Translate Disclaimer
A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:
Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.
Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).
Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.
Saskatchewan's COVID-19 Vaccine Delivery Plan is designed to save lives and stop the spread of COVID-19. The information on this page is updated frequently and is subject to change based on vaccine availability and the latest COVID-19 data.
Currently, all residents age five years and older are eligible to be vaccinated against COVID-19 in Saskatchewan.
Health Canada has approved one- and two-dose COVID-19 vaccines for use in Canada.
For single-dose vaccinations (Janssen), you are fully vaccinated 14 days after your immunization.
For two-dose vaccinations (Pfizer BioNTech, AstraZeneca, Moderna, Novavax), you are fully vaccinated 14 days following your second dose.
Additional doses are strongly recommended for optimal protection against current COVID-19 variants.
If you have designated medical conditions affecting your immune system (see table below), you are eligible to receive your fourth dose three months following your third dose.
All individuals 12+ are eligible for a third dose at this time, and all residents 50+ are eligible to receive a fourth dose.
|Population||Doses in Primary Series||Interval to First Booster (mRNA preferred)||Interval to Second Booster
|Age 18+ living in long term care, personal care homes or other senior congregate living settings||2||4 months||4 months|
|Age 50+ all individuals||2||4 months||4 months|
|Age 50+ who received Janssen vaccine||1||2 months||4 months|
|Age 50+ who received AstraZeneca/COVISHIELD or mixed doses followed by mRNA (Pfizer, Moderna) doses for travel||varies||4 months||4 months regardless of # of doses previously received|
|Age 18–49 who received AstraZeneca/COVISHIELD or mixed doses followed by mRNA (Pfizer, Moderna) doses for travel||varies||4 months||Currently not eligible|
Age 50+ clinically vulnerable individuals including:
Note vulnerable individuals age 12-49 are not currently eligible for second booster doses.
|2||4 months||4 months|
Age 50+ moderately to severely immune compromised individuals that includes:
Stem cell and organ transplant recipients; recipients in active treatment (chemotherapy, targeted therapies, immunotherapy) for malignant, hematologic disorders; recipients of an anti-CD20 agent (e.g. rituximab, ocrelizumab, ofatumumab).
Individuals on immunosuppressive or immunomodulating therapy at the time of vaccination including:
Individuals with chronic immune-mediated inflammatory disease who were receiving or had received immunosuppressive therapy prior to vaccination including: methotrexate, azathioprine
Individuals who had received high-dose steroids (equivalent to ≥40mg prednisolone per day for more than a week) for any reason in the month before vaccination.
Note moderately to severely immune compromised individuals age 12-49 are not currently eligible for second booster doses.
|3||3 months||4 months|
Information on receiving your COVID-19 vaccination is available.
Designated vaccines, including Novavax, and fourth doses for eligible residents of First Nations and Métis communities and the Northern Service Administration District are available by SHA appointment made by calling 1-833-SASKVAX (727-5829) only.
Note that AstraZeneca is no longer available in Saskatchewan as of April 30, 2022. Booster doses do not need to match your previous two dose COVID-19 vaccinations. If you received two doses of AstraZeneca, it is recommended and safe to receive an mRNA vaccine booster immunization.
We need your feedback to improve saskatchewan.ca. Help us improve